Who Owns IMUX?

Immunic, Inc. — Institutional Ownership & 13F Holdings

$10.42

+0.44 (+4.41%)

Market Cap

$98.5M

Shares Outstanding

98,685,393

Institutional Holders

64

Total Inst. Value

$44.6M

% of Float Held

42.3%

QoQ Holder Change

+8

Institutional data as of Q1 2025

New Positions

13

Closed Positions

15

Increased

12

Decreased

17

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1BVF INC/IL$9.7M8,902,972
2Soleus Capital Management, L.P.$7.9M7,293,007
3Avidity Partners Management LP$4.9M4,454,408
4VANGUARD GROUP INC$4.3M3,931,548
5Focus Partners Wealth$2.8M2,583,457
6Omega Fund Management, LLC$1.9M1,788,160
7NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO$1.6M1,500
8ADAGE CAPITAL PARTNERS GP, L.L.C.$1.5M1,398,600
9GEODE CAPITAL MANAGEMENT, LLC$1.1M976,152
10SUSQUEHANNA INTERNATIONAL GROUP, LLP$1.0M949,648

Biggest Buyers & Sellers This Quarter

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold IMUX?

As of Q1 2025, 64 institutional investors report holding IMUX (Immunic, Inc.) in their 13F filings.

What percentage of Immunic, Inc. is owned by institutions?

Institutional investors hold approximately 42.3% of Immunic, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most IMUX?

The largest institutional holder of IMUX is BVF INC/IL with $9.7M in shares.

Are institutions buying or selling IMUX?

This quarter, 13 institutions opened new positions in IMUX and 15 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.